Invention Grant
- Patent Title: Beta-lactamase variants
-
Application No.: US16757968Application Date: 2018-10-24
-
Publication No.: US11365403B2Publication Date: 2022-06-21
- Inventor: Jean De Gunzburg , Jean-Denis Docquier
- Applicant: Da Volterra , Bioaster
- Applicant Address: FR Paris; FR Lyons
- Assignee: Da Volterra,Bioaster
- Current Assignee: Da Volterra,Bioaster
- Current Assignee Address: FR Paris; FR Lyons
- Agency: Cesari & McKenna, LLP
- Priority: EP17198414 20171025
- International Application: PCT/EP2018/079223 WO 20181024
- International Announcement: WO2019/081614 WO 20190502
- Main IPC: C12N9/84
- IPC: C12N9/84 ; C12N1/21 ; A61K38/50 ; C12N9/86 ; A61K31/407 ; A61K31/496 ; A61K31/546 ; A61K38/00

Abstract:
The present invention relates to an isolated polypeptide having beta-lactamase activity and nucleic acid sequences encoding the polypeptide. The isolated polypeptide of the invention is a VIM-2 variant with improved properties such as improved protease stability, stability in intestinal medium, improved activity against one or more antibiotics, improved specific activity and/or improved production in a host cell.
Public/Granted literature
- US20200318094A1 BETA-LACTAMASE VARIANTS Public/Granted day:2020-10-08
Information query
IPC分类: